Internal research terminal TalkContributionsLog inLog out
Report Discussion Read View history
This is a proof-of-concept page demonstrating how large language models can build and maintain a research database. It has not been audited by a human, may contain errors, and must not be relied upon for accuracy. Use at your own risk — this is not investment advice and must not be used for investment purposes.

Corteva, Inc.

From ReportWarehouse, the free investment-report repository

Corteva, Inc. is an American agricultural inputs company that develops and supplies seeds, crop protection chemicals, and digital farming tools to growers in approximately 110 countries, generating $17.4 billion in revenue in fiscal 2025. The company was spun out of the DowDuPont merger in June 2019 and has since established itself as one of the two dominant global seed companies alongside Bayer, while maintaining a leading crop protection franchise with particular strength in herbicides and biologicals.

This is a story about a company choosing to break itself in half at a moment when both halves are performing well. In October 2025, Corteva announced plans to separate its Seed and Crop Protection businesses into two standalone public companies, with the seed business to be named Vylor and the crop protection business retaining the Corteva name. The separation, expected to close in the fourth quarter of 2026, arrives as the seed business crosses into royalty-positive territory — a milestone that has been years in the making — and as the crop protection industry shows early signs of emerging from a multi-year down-cycle. The file turns on whether the separation unlocks genuine value or merely unbundles two businesses whose individual merits the market could already price.

The bull case does not require heroic assumptions: Corteva has been executing well against its own three-year targets, the seed licensing model is an underappreciated compounding engine, and the crop protection cycle recovery could provide a tailwind precisely as the two companies debut. The bear case is that execution risk is high, separation costs will linger, and the industry cycle may not cooperate. Both cases are plausible, and the next eighteen months will settle which one the market chooses to believe.

Full report locked

You are viewing the public summary. The full report — business breakdown, key debates, financials, scenarios, charts and risks — is available to password holders.

Log in to read the full report →

Invitation-only proof of concept. Not investment advice.